3,138
Views
45
CrossRef citations to date
0
Altmetric
Research Article

The chemo-prophylactic efficacy of an ethanol Moringa oleifera leaf extract against hepatocellular carcinoma in rats

, , &
Pages 1458-1466 | Received 21 Jun 2016, Accepted 11 Mar 2017, Published online: 27 Mar 2017

References

  • Al-Rejaie SS, Aleisa AM, Al-Yahya AA. 2009. Progression of diethylnitrosamine-induced hepatic carcinogenesis in carnitine-depleted rats. World J Gastroenterol. 15:1373–1380.
  • Amin A, Hamza AA, Bajbouj KS. 2011. A potential candidate for a novel anticancer drug against hepatocellular carcinoma. Hepatology. 254:857–867.
  • Arabshahi DS, Devi V, Urooj A. 2007. Evaluation of antioxidant activity of some plant extracts and their heat, pH and storage stability. Food Chem. 100:1100–1105.
  • Arya S, Asharaf S, Parande C. 1988. Hepatitis B and delta markers in primary hepatocellular carcinoma patients in the Gizan area of Saudi Arabia. APMIS. 3:30–38.
  • Asahina Y, Tsuchiya K, Tamaki N, Hirayama I, Tanaka T, Sato M. 2010. Effect of aging on risk for hepatocellular carcinoma in chronic hepatitis C virus infection. Hepatology. 52:518–527.
  • Banakar MC, Paramasivan SK, Chattopadhyay MB. 2004. 1-alpha, 25-Dihydroxyvitamin D3 prevents DNA damage and restores antioxidant enzymes in rat hepatocarcinogenesis induced by diethylnitrosamine and promoted by phenobarbital. World J Gastroenterol. 10:1268–1275.
  • Bansal AK, Bansal M, Soni G. 2005. Protective role of vitamin E pre-treatment on N-nitrosodiethylamine induced oxidative stress in rat liver. Chem Biol Interact. 156:101–111.
  • Becker FF, Sell S. 1979. Differences in serum alpha-fetoprotein concentrations during the carcinogenic sequences resulting from exposure to diethylnitrosamine or acetylaminofluorene. Cancer Res. 39:1437–1442.
  • Bishayee A, Chatterjee M. 1995. Inhibitory effect of vanadium on rat liver carcinogenesis initiated with diethylnitrosamine and promoted by phenobarbital. Br J Cancer. 71:1214–1220.
  • Bryja V, Gradl D, Schambony A. 2007. beta-Arrestin is a necessary component of Wnt/beta-catenin signaling in vitro and in vivo. Proc Natl Acad Sci USA. 104:6690–6695.
  • Cui-Li Z, Tao Z, Xiu-Lan Z, Li-Hua Y, Zhen-Ping Z, Ke-Qin X. 2012. Protective effects of garlic oil on hepatocarcinoma induced by N-nitrosodiethylamine in rats. Int J Biol Sci. 8:363–374.
  • Danial NN, Korsmeyer SJ. 2004. Cell death: critical control points. Cell. 116:205–219.
  • DeWire SM, Ahn S, Lefkowitz RJ. 2007. beta-Arrestins and cell signaling. Annu Rev Physiol. 69:483–510.
  • Edlich F, Banerjee S, Suzuki M. 2011. Bcl-x(L) retrotranslocates Bax from the mitochondria into the cytosol. Cell 145:104–116.
  • Fabregat I. 2009. Dysregulation of apoptosis in hepatocellular carcinoma cells. World J Gastroenterol. 15:513–520.
  • Ferenci P, Fried M, Labrecque D, Bruix J, Sherman M, Omata M; World Gastroenterology Organisation Guidelines and Publications Committee. 2010. Hepatocellular carcinoma (HCC): a global perspective. J Gastrointestin Liver Dis. 19:311–317.
  • Finnberg N, Stenius U, Hogberg J. 2000. Xenobiotics modulate the p53 response to DNA damage in preneoplastic enzyme-altered foci in rat liver; effects of diethylnitrosamine and phenobarbital. Toxicol Sci. 54:95–103.
  • Fukamachi Y, Karasaki Y, Sugiura T. 1998. Zinc suppresses apoptosis of U937 cells induced by hydrogen peroxide through an increase of the Bcl-2/Bax ratio. Biochem Biophys Res Commun. 246:364–369.
  • Gardner CR. 2004. Anticancer drug development based on modulation of the Bcl-2 family core apoptosis mechanism. Expert Rev Anticancer Ther. 4:1157–1177.
  • Hagen TM, Huang S, Curnutte J. 1994. Extensive oxidative DNA damage in hepatocytes of transgenic mice with chronic active hepatitis destined to develop hepatocellular carcinoma. Proc Natl Acad Sci USA. 91:12808–12812.
  • Iqbal S, Bhanger M. 2006. Effect of season and production location on antioxidant activity of Moringa oleifera leaves grown in Pakistan. J Food Compost Anal. 19:544–551.
  • Jemal A, Bray F, Center MM. 2011. Global cancer statistics. CA Cancer J Clin. 61:69–90.
  • Kamdem L, Siest G, Magdalou J. 1982. Differential toxicity of aflatoxin B1 in male and female rats: relationship with hepatic drug-metabolizing enzymes. Biochem Pharmacol. 31:3057–3062.
  • Khan N, Adhami VM, Mukhtar H. 2010. Apoptosis by dietary agents for prevention and treatment of prostate cancer. Endocr Relat Cancer. 17:39–52.
  • Khan MS, Devaraj H, Devaraj N. 2011. Chrysin abrogates early hepatocarcinogenesis and induces apoptosis in N-nitrosodiethylamine-induced preneoplastic nodules in rats. Toxicol Appl Pharmacol. 251:85–94.
  • Lin PH, Lin CH, Huang CC. 2007. 2, 3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) induces oxidative stress, DNA strand breaks, and poly(ADP-ribose) polymerase-1 activation in human breast carcinoma cell lines. Toxicol Lett. 172:146–158.
  • Lippert M, Papadopoulos N, Javadpour NR. 1981. Role of lactate dehydrogenase isoenzymes in testicular cancer. Urology. 18:50–53.
  • Livak KJ, Schmittgen TD. 2001. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-delta delta C(T)) method. Methods. 25:402–408.
  • Llovet JM, Burroughs A, Bruix J. 2003. Hepatocellular carcinoma. Lancet. 362:1907–1917.
  • Loeppky RN. 2009. The mechanism of bioactivation of N-nitrosodiethanolamine. Drug Metab Rev. 31:175–193.
  • Lukacinova A, Mojzis J, Benacka R, Keller J, Maguth T, Kurila P. 2008. Preventive effects of flavonoids on alloxan-induced diabetes mellitus in rats. Acta Vet Brno. 77:175–182.
  • Lykkesfeldt J. 2007. Malondialdehyde as biomarker of oxidative damage to lipids caused by smoking. Clin Chim Acta. 380:50–58.
  • Ma L, Wen S, Zhan Y. 2008. Anticancer effects of the Chinese medicine matrine on murine hepatocellular carcinoma cells. Planta Med. 74:245–251.
  • Mc-Intrye N, Rosalki S. 1992. Biochemical investigation in the management of liver diseases. In: Prieto J, Rodes J, Shafritz DA, editors. Hepatobiliary diseases. Berlin: Springer-Verlag; p. 39–71.
  • NIH. 1996. Guide for the care and use of laboratory animal. NIH publication no. 86-23, Bethesda, MD: Public health service, NIH.
  • Pakade V, Cukrowska E, Chimuka L. 2013. Comparison of antioxidant activity of Moringa oleifera and selected vegetables in South Africa. S Afr J Sci. 109:1–5.
  • Qi F, Li A, Inagaki Y. 2012. Induction of apoptosis by cinobufacini preparation through mitochondria- and Fas-mediated caspase-dependent pathways in human hepatocellular carcinoma cells. Food Chem Toxicol. 50:295–302.
  • Ramakrishnan G, Raghavendran HR, Vinodhkumar R. 2006. Suppression of N-nitrosodiethylamine induced hepatocarcinogenesis by silymarin in rats. Chem Biol Interact. 161:104–114.
  • Saalu LC, Osinubi AA, Akinbami AA, Yama OE, Oyewopo AO, Enaibe BU. 2011. Moringa oleifera Lamarck (drumstick) leaf extract modulates the evidences of hydroxyurea-induced testicular derangement. Int J Appl Res Nat Prod. 4:32–45.
  • Sadek KM. 2014. Chemotherapeutic efficacy of an ethanolic Moringa oleifera leaf extract against chromium-induced testicular toxicity in rats. Andrologia. 46:1047–1054.
  • Sarada SK, Himadri P, Ruma D. 2008. Selenium protects the hypoxia induced apoptosis in neuroblastoma cells through upregulation of Bcl-2. Brain Res. 1209:29–39.
  • Sell S, Becker F, Leffert HL, Sborn KO, Salman J, Ombardi BL. 1983. α-Fetoprotein as a marker for early events and carcinoma development during chemical hepatocarcinogenesis. Environ Sci Res. 29:271–293.
  • Shaarawy SM, Tohamy AA, Elgendy SM. 2009. Protective effects of garlic and silymarin on NDEA-induced rats hepatotoxicity. Int J Biol Sci. 5:549–557.
  • Siddhuraju P, Becker K. 2003. Antioxidant properties of various solvent extracts of total phenolic constituents from three different agroclimatic origins of drumstick tree (Moringa oleifera Lam) leaves. J Agric Food Chem. 51:2144–2155.
  • Smolin LA, Grosvenor MB. 2007. Nutrition science and applications. New York: John Wiley & Sons Inc.
  • Sreelatha S, Padma PR. 2010. Antioxidant activity and total phenolic content of Moringa oleifera leaves in two stages of maturity. Plant Foods Hum Nutr. 64:303–311.
  • Tabone M, Pellicano R. 2006. Prevention of intrahepatic hepatocarcinoma recurrence in patients with viral cirrhosis: two potential options. Minerva Gastroenterol Dietol. 52:47–52.
  • Tse C, Shoemaker AR, Adickes J. 2008. ABT-263: a potent and orally bioavailable Bcl-2 family inhibitor. Cancer Res. 68:3421–3428.
  • Tsubota A, Yoshikawa T, Nariai K. 2008. Bovine lactoferrin potently inhibits liver mitochondrial 8-OHdG levels and retrieves hepatic OGG1 activities in Long-Evans Cinnamon rats. J Hepatol. 48:486–493.
  • Vasquez-Garzon VR, Arellanes-Robledo J, Garcia-Roman R. 2009. Inhibition of reactive oxygen species and pre-neoplastic lesions by quercetin through an antioxidant defense mechanism. Free Radic Res. 43:128–137.
  • Zimmer R, Thomas P. 2001. Mutations in the carcinoembryonic antigen gene in colorectal cancer patients: implications on liver metastasis. Cancer Res. 61:2822–2826.